Elution behavior of a 3D-printed, milled and conventional resin-based occlusal splint material.

3D printing Additive manufacturing Biocompatibility Digital light processing Elution Methacrylates Polymethyl methacrylate Rapid prototyping Residual monomers Splint materials

Journal

Dental materials : official publication of the Academy of Dental Materials
ISSN: 1879-0097
Titre abrégé: Dent Mater
Pays: England
ID NLM: 8508040

Informations de publication

Date de publication:
04 2021
Historique:
received: 21 09 2020
revised: 12 12 2020
accepted: 20 01 2021
pubmed: 3 3 2021
medline: 24 4 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

The elution of unpolymerized (co-)monomers and additives from methacrylic resin-based materials like polymethyl methacrylate (PMMA) can cause adverse side effects, such as mutagenicity, teratogenicity, genotoxicity, cytotoxicity and estrogenic activity. The aim of this study was to quantify the release and the cytotoxicity of residual (co-)monomers and additives from PMMA-based splint materials under consideration of real splint sizes. Three different materials used for additive (3D printing), subtractive (milling) and conventional (powder and liquid) manufacturing were examined. The splint materials SHERAprint-ortho plus (additive), SHERAeco-disc PM20 (subtractive) and SHERAORTHOMER (conventional) were analysed. 16 (n = 4) sample discs of each material (6 mm diameter and 2 mm height) were polished on the circular and one cross-section area and then eluted in both distilled water and methanol. The discs were incubated at 37 °C for 24 h or 72 h and subsequently analysed by gas chromatography/mass spectrometry (GC/MS) for specifying and quantifying released compounds. XTT-based cell viability assays with human gingival fibroblasts (HGFs) were performed for Tetrahydrofurfuryl methacrylate (THFMA), 1,4-Butylene glycol dimethacrylate (BDDMA) and Tripropylenglycol diacrylate (TPGDA). In order to project the disc size to actual splint sizes in a worst-case scenario, lower and upper jaw occlusal splints were designed and volumes and surfaces were measured. For SHERAeco-disc PM20 and for SHERAORTHOMER no elution was determined in water. SHERAprint-ortho plus eluted the highest THFMA concentration of 7.47 μmol/l ±2,77 μmol/l after 72 h in water. Six (co-)monomers and five additives were detected in the methanol eluates of all three materials tested. The XTT-based cell viability assays resulted in a EC With the solvent methanol, released components from the investigated splint materials exceeded cytotoxic concentrations in HGFs calculated for a worst-case scenario in splint size. In the water eluates only the methacrylate THFMA could be determined from SHERAprint-ortho plus in concentrations below cytotoxic levels in HGFs.

Identifiants

pubmed: 33648744
pii: S0109-5641(21)00044-0
doi: 10.1016/j.dental.2021.01.024
pii:
doi:

Substances chimiques

Composite Resins 0
Methacrylates 0
Polymethyl Methacrylate 9011-14-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

701-710

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Lennart Wedekind (L)

Department of Prosthetic Dentistry, University Hospital, LMU Munich, Germany.

Jan-Frederik Güth (JF)

Department of Prosthetic Dentistry, University Hospital, LMU Munich, Germany; Department of Prosthodontics, Center for Dentistry and Oral Medicine (Carolinum), Goethe-University Frankfurt am Main. Electronic address: gueth@med.uni-frankfurt.de.

Josef Schweiger (J)

Department of Prosthetic Dentistry, University Hospital, LMU Munich, Germany.

Maximilian Kollmuss (M)

Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich, Germany.

Franz-Xaver Reichl (FX)

Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, Germany.

Daniel Edelhoff (D)

Department of Prosthetic Dentistry, University Hospital, LMU Munich, Germany.

Christof Högg (C)

Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH